ARCHIVES

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: NASA Procurement Specialist Names NEW NCI Contracts Chief; NIH Delays CREG Approval

January 3, 1975

Cancer Panel Statement On Access To Cancer Care.

October 6, 2000

Group Chairmen Object To “Directive” Language In Proposed Intergroup Study Guidelines

January 13, 1984

Litton Loses To PRI On Largest Frederick Contract, Competing Against Hopkins For Science Program

August 27, 1982

NTP Board Okays Modification Of Bioassay Protocols

April 9, 1982

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007